Table 3.
Risk factors for liver transplantation (n = 29) versus survival without (n = 63) on day-60
| Characteristics | Univariate analysis | Multivariable analysis | ||
|---|---|---|---|---|
| Odds ratio | p value | Odds ratio | p value | |
| Comorbidity | 0.12 (0.04–0.35) | 0.001 | 0.10 (0.03–0.33) | 0.001 |
| Growth failure | 2.02 (0.76–5.39) | 0.158 | ||
| ACLF | 9.01 (2.55–31.78) | 0.001 | 5.02 (1.24–20.23) | 0.023 |
| Sepsis | 1.74(0.71–4.25) | 0.225 | ||
| Biliary atresia | 1.37 (0.56–3.34) | 0.485 | ||
| INR ≥ 2.5 | 2.71 (1.04–7.08) | 0.041 | ||
| Bilirubin ≥ 300 μmol/L | 2.02 (0.72–5.61) | 0.177 | ||
| pCLIF-SOFA | 1.19 (1.03–1.38) | 0.016 | ||
| pCLIF-SOFA ≥ 7 | 2.85 (1.06–7.64) | 0.036 | 5.07 (1.47–17.47) | 0.010 |
| PELD | 1.05 (1.00–1.13) | 0.021 | ||
Odds ratio are expressed as 95% (confidence interval). On multivariable analysis, centre effect was not significant (p = 0.13)
ACLF acute-on-chronic liver failure, INR International Normalized Ratio, pCLIF-SOFA Paediatric Chronic Liver Failure-Sequential Organ Failure Assessment score, PELD paediatric end-stage liver disease